| scholarly article | Q13442814 |
| P2093 | author name string | Eirini Nestoridi | |
| Julie R Ingelfinger | |||
| Eric F Grabowski | |||
| Rafail I Kushak | |||
| Olga Tsukurov | |||
| P2860 | cites work | AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 |
| Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats | Q24800784 | ||
| A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 | ||
| Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura | Q28214974 | ||
| Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data | Q29616220 | ||
| Effect of CsA on the expression of renin and angiotensin type 1 receptor genes in the rat kidney. | Q30467641 | ||
| Enhanced low shear stress induced platelet aggregation by Shiga-like toxin 1 purified from Escherichia coli O157. | Q31927907 | ||
| Markers of endothelial cell activation and injury in childhood haemolytic uraemic syndrome | Q33329776 | ||
| Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. | Q33338331 | ||
| Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome | Q33339341 | ||
| Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome | Q33340490 | ||
| Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome | Q33365904 | ||
| Systemic hypertension and plasma renin activity in children with the hemolytic-uremic syndrome. | Q33481287 | ||
| Plasma renin activity in haemolytic uraemic syndrome | Q33491051 | ||
| Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome. | Q33503880 | ||
| Prothrombotic effects of angiotensin | Q33817533 | ||
| Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation | Q33890331 | ||
| Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. | Q34262285 | ||
| Role of inflammatory mediators in thrombogenesis | Q34542369 | ||
| Physiology of local renin-angiotensin systems. | Q34543927 | ||
| Interaction of cyclosporine A and the renin-angiotensin system; new perspectives | Q34551166 | ||
| Endothelial dysfunction and inflammation: What is the link? | Q35106721 | ||
| Pharmacologic blockade of the renin-angiotensin system: vascular benefits beyond commonly understood pharmacologic actions | Q35549761 | ||
| The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking. | Q36849029 | ||
| Cultured human endothelial cells generate tissue factor in response to endotoxin | Q36990717 | ||
| Cell biology of tissue factor, the principal initiator of blood coagulation | Q41070406 | ||
| Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. | Q42138675 | ||
| Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy | Q43695930 | ||
| Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes | Q46544071 | ||
| Angiotensin-Converting Enzyme Inhibitors Downregulate Tissue Factor Synthesis in Monocytes | Q57398912 | ||
| The functional expression of tissue factor by fibroblasts and endothelial cells under flow conditions | Q70751710 | ||
| Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction | Q73081786 | ||
| Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells | Q73553882 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 221-231 | |
| P577 | publication date | 2007-11-30 | |
| P1433 | published in | Pediatric Nephrology | Q15749796 |
| P1476 | title | Role of the renin angiotensin system in TNF-alpha and Shiga-toxin-induced tissue factor expression | |
| P478 | volume | 23 |
| Q42924690 | Aliskiren, a renin inhibitor, downregulates TNF-α-induced tissue factor expression in HUVECS. |
| Q37812379 | Angiotensin II, tissue factor and the thrombotic paradox of hypertension |
| Q34213566 | Enzymatic processing of angiotensin peptides by human glomerular endothelial cells |
| Q33952458 | Lipopolysaccharide renders transgenic mice expressing human serum amyloid P component sensitive to Shiga toxin 2 |
| Q33386199 | Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome |
| Q37711288 | Targeting renin-angiotensin system in malignant hypertension in atypical hemolytic uremic syndrome. |
| Q41031121 | The effect of high glucose on the inhibitory action of C21, a selective AT2R agonist, of LPS-stimulated tissue factor expression in human mononuclear cells |
| Q33380757 | Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). |
| Q33383031 | Treatment options for HUS secondary to Escherichia coli O157:H7. |
Search more.